• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATH
Click for more information
25.0% 0.5¢

ALTERITY THERAPEUTICS LIMITED

Market Cap $20.98M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company.... Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase II clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ATH
JULY IS HERE !!! 		08:06 40 6.7K
08:06 Last post  RebekahChambers Comments Created with Sketch.  40  Views Created with Sketch.  6.7K 
ATH
36 genes related to iron in brain 		03/07/24 0 106
03/07/24 Last post  pivalde Comments Created with Sketch.  0  Views Created with Sketch.  106 
ATH
Synucleinopathy: inpact on lipids of mitochondria and ER 		03/07/24 0 116
03/07/24 Last post  pivalde Comments Created with Sketch.  0  Views Created with Sketch.  116 
ATH
Bacteria triggering inflammation contributes to PD ???? 		03/07/24 2 422
03/07/24 Last post  MrLearner Comments Created with Sketch.  2  Views Created with Sketch.  422 
ATH
Prevalence of PD increasing 		01/07/24 0 152
01/07/24 Last post  pivalde Comments Created with Sketch.  0  Views Created with Sketch.  152 
ATH
Ann: Notification regarding unquoted securities - ATH 		28/06/24 0 299
28/06/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  299 
ATH
Coffee, tobacco and asperin delays getting PD 		28/06/24 4 999
28/06/24 Last post  Scottsmyname Comments Created with Sketch.  4  Views Created with Sketch.  999 
ATH
Expected Alterity future if successful 		28/06/24 2 968
28/06/24 Last post  Stockman Comments Created with Sketch.  2  Views Created with Sketch.  968 

See All Discussions arrow Created with Sketch.

Timeline

Notification regarding unquoted securities - ATH
28 Jun 16:58
 
Alterity to Present at Hidden Gems in Life Sciences Webinar
13 Jun 08:42
 
Webcast Today - New Data from bioMUSE Natural History Study
30 May 08:39
 
Notification of cessation of securities - ATH
21 May 15:19
 
Phase 2 DMC Recommends Continuing Clinical Trial as Planned
08 May 08:27
 
Ceasing to be a substantial holder
08 May 08:20
 
View More arrow Created with Sketch.

Featured News

BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
ARU Cashed up Arafura locks in $171M German export agency deal; locks in NdPr offtake for wind turbines
right-arrow Created with Sketch.
NEWS Finding properties tenants will want to rent
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
(20min delay)
Last
0.5¢ 		Change
0.001(25.0%) 		Mkt cap ! $20.98M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $651 130.1K

Buyers (Bids)

No. Vol. Price($)
57 67445774 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 38554801 23
View Market Depth
Last trade - 09.59am 04/07/2024 (20 minute delay) ?
ATH (ASX) Chart

Top Stories

ACCC raises competition concerns about acquisition of Lendlease projects

The ACCC has published a Statement of Issues on competition risks posed by the intended acquisition of 12 residential community projects.
Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring Sun Silver executive director Gerard O'Donovan discusses a 6,216 grams Fort Intercept at the Maverick Spring Silver Project from historical data and drill assessments.
Alkane Resources hit 57.2Kozpa gold production through FY24 – and eyeing 70Ktpa in FY26 Alkane Resources has announced its gold production metrics for full year FY24 coming in at 57,217oz – brushing just short of upper guidance.
Swagman shoot proves plentiful for AIC, with Cu beyond 3% close to Eloise AIC Mines Ltd has progressed drilling at its Swagman discovery in Queensland, finding copper grading beyond 3 percent.
XReality Group wins $800K contract from Aus Government for military and police VR training tech xReality Group has announced its receipt of an $800K contract from to provide its Virtual Reality (VR) training tech.

Featured News

NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
NEWS Finding properties tenants will want to rent
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
NEWS Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.